Wang Hankun, Li Dan, Song Li, Zhou Chao, Huang Xinhua, Huang Weifeng, Zhang Ding, Ding Cairong, Song Jingrui, Zhou Shuang, Luo Chunyan, Xia Xuan, Gonzales Jacqueline, Via Laura E, Wang Decheng
Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang 443002, PR China; College of Basic Medical Sciences, Yichang Key Laboratory of Infection and Inflammation, China Three Gorges University, Yichang 443002, PR China.
Department of Tuberculosis, The Third People's Hospital of Yichang, Yichang 443003, PR China.
Int J Biol Macromol. 2025 Sep;321(Pt 1):146193. doi: 10.1016/j.ijbiomac.2025.146193. Epub 2025 Jul 21.
Mycobacterium tuberculosis, a typical intracellular parasite that causes tuberculosis, is ranked as the top infectious killer for humans in annual WHO reports. Pathogenic mycobacterium has evolved numerous strategies to favor their intracellular survival including a unique lipid-rich-cell-wall and granuloma formation during infection. Phthiocerol dimycocerosate (PDIM) is a critical virulence factor of mycobacteria including Mycobacterium marinum (Mm), which manipulate host immune responses and granuloma induction and facilitate immune evasion, but the mechanisms still remain unclear. We used an AACT/SILAC-based-quantitative proteomic approach to determine PDIM-responsive proteomics during Mm-infection. A major difference was the high abundance of Gal-3 in WT_Mm-infected cells not observed in PDIM-deficient infections. Gal-3 induction by PDIM-replete bacteria was primarily via Toll-like-receptor 2, and also engaged TGF-β non-classical-pathway. Elevated Gal-3 in macrophages prevented the turnover and translocation of NF-κB to effectively modulate the profile of inflammatory cytokines. Gal-3 Silencing effectively reduced tissue damage induced in mice by PDIM-expressing Mm. We found upregulated Gal-3 in the serum and BALF of clinical tuberculosis cases, which decreased significantly after effective chemotherapy. Our findings demonstrated that upregulated Gal-3 not only plays an important role in regulating host immune response and granuloma formation, but also suggests that targeting-Gal-3 therapy could be a promising anti-tuberculosis strategy.
结核分枝杆菌是一种典型的细胞内寄生虫,可导致结核病,在世卫组织的年度报告中被列为人类头号传染性杀手。致病性分枝杆菌已进化出多种策略以利于其在细胞内存活,包括独特的富含脂质的细胞壁以及感染期间形成肉芽肿。结核硬脂酸双分枝菌酸酯(PDIM)是包括海分枝杆菌(Mm)在内的分枝杆菌的关键毒力因子,它可操纵宿主免疫反应和肉芽肿诱导并促进免疫逃逸,但其机制仍不清楚。我们使用基于AACT/SILAC的定量蛋白质组学方法来确定Mm感染期间对PDIM有反应的蛋白质组学。一个主要差异是在野生型Mm感染的细胞中高丰度的半乳糖凝集素-3(Gal-3),而在PDIM缺陷感染中未观察到。富含PDIM的细菌诱导Gal-3主要是通过Toll样受体2,并且还涉及转化生长因子-β非经典途径。巨噬细胞中Gal-3升高可阻止核因子-κB(NF-κB)的周转和易位,从而有效调节炎性细胞因子的谱。Gal-3沉默可有效减少表达PDIM的Mm在小鼠中诱导的组织损伤。我们发现临床结核病病例的血清和支气管肺泡灌洗液(BALF)中Gal-3上调,有效化疗后其显著下降。我们的研究结果表明,上调的Gal-3不仅在调节宿主免疫反应和肉芽肿形成中起重要作用,而且还表明靶向Gal-3治疗可能是一种有前景的抗结核策略。